Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Minority Interest (2016 - 2025)

vTv Therapeutics' Minority Interest history spans 12 years, with the latest figure at -$357000.0 for Q2 2025.

  • For Q2 2025, Minority Interest changed N/A year-over-year to -$357000.0; the TTM value through Jun 2025 reached -$357000.0, changed N/A, while the annual FY2024 figure was $2.1 million, 65.72% down from the prior year.
  • Minority Interest for Q2 2025 was -$357000.0 at vTv Therapeutics, down from $977000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $62.6 million in Q1 2021 and bottomed at -$357000.0 in Q2 2025.
  • The 5-year median for Minority Interest is $16.2 million (2022), against an average of $20.3 million.
  • The largest annual shift saw Minority Interest crashed 77.07% in 2022 before it soared 36.42% in 2023.
  • A 5-year view of Minority Interest shows it stood at $25.0 million in 2021, then plummeted by 33.58% to $16.6 million in 2022, then crashed by 63.02% to $6.1 million in 2023, then tumbled by 65.72% to $2.1 million in 2024, then tumbled by 116.98% to -$357000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Minority Interest are -$357000.0 (Q2 2025), $977000.0 (Q1 2025), and $2.1 million (Q4 2024).